h1,h2,h3 { color: #000000;background-color: #FFB903; font-family: Verdana,sans-serif; } ul,ol { font-family: Verdana,sans-serif; } New on MS Crossroads


  • Quick start 
  • New on crossroads 
  • MS-stuff 
  • Other MS pages 
  • Support 
  • Tips 
  • MS research 
  • Researchers 
  • Medline 
  • Abstracts 
  • MS medication 
  • Speculation 
  • Medical stuff 
  • Computer 
    Aapo Halko, my MS
  • News

  • AUTO-IMMUNE news collected by Irwin Mortman. (Here you can find the latest ms news and abstracts.)
  • MS in the news
  • Current research updates by NMSS. 
  • New on MS crossroads


    March 24, 2004 The F.D.A. approves Tysabri, formerly known as Antegren

    July 31, 2004 High-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study.
    May 30 Campath-1H for ms, David's experience, links.
    April 30, 2004 Abstracts from the 2004 AAN meeting
    September 26, 2003 Dose and Frequency of Administration of Interferon-Beta Affect its Efficacy in Multiple Sclerosis. Clin Drug Invest 23(9) 2003. Registration required, free.
    September 8, 2003 New and emerging treatment options for multiple sclerosis
    August 12, 2003 Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
    August 12, 2003 Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
    July 23, 2003 Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis
    June 26, 2003 natalizumab PubMed. ANTEGREN (natalizumab) by Elan.
    June 18, 2003 ACTRIMS 2003
    June 9, 2003 ECTRIMS 2003
    June 3, 2003 Fatigue associated with multiple sclerosis: diagnosis, impact and management
    April 23, 2003 Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis, Published in Nature. Collateral damage repaired by LAWRENCE STEINMAN.
    April 23, 2003 Multiple sclerosis: a two-stage disease by LAWRENCE STEINMAN.
    April 10, 2003 American Academy of Neurology (AAN) 55th Annual Meeting Speakers' Abstracts about Multiple Sclerosis
    March 24, 2003 Betaseron (Interferon Beta-1b) Gains Expanded FDA Labeling Approval for Treating Relapsing Forms of Multiple Sclerosis
    March 11, 2003 Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis.
    February 13, 2003 Beta-Interferon treatment does not always slow the progression of axonal injury in ms